HealthAI CEO joins new UK commission to help accelerate use of Responsible AI in Health

Dr. Ricardo Baptista Leite, CEO of HealthAI – ‘The Global Agency for Responsible AI in Health’, joins the UK’s National Commission on the Regulation of AI in Healthcare as a founding member. The commission unites clinical leaders, patient advocates, and leading tech firms to make the NHS the most AI-enabled healthcare system in the world.

The NHS should gain quicker access to the latest AI tools, thanks to a new National Commission tasked with advising the Medicines and Healthcare products Regulatory Agency (MHRA) on how to revise the regulatory rulebook on AI in healthcare, which is expected to be published next year.

The UK National Commission on the Regulation of AI in Healthcare will bring in experts from big tech companies – like Google and Microsoft – as well as leading clinicians, researchers, and patient advocates, to advise regulators on how to speed up access to the latest tech in a safe way, so British patients can safely benefit from it first.

In the meantime, the Commission will also examine accelerating access to AI assistants for doctors, which help by taking notes, with regulatory uncertainty currently hindering the technology’s development. Early tests of ‘Ambient Voice Technology’ show that it has reduced admin, which means that more people could be seen in A&E and clinicians could spend more time focusing on patients.

The Commission will also help by providing regulatory clarity on various AI tools, such as those for radiology and pathology, as well as remote monitoring systems to support virtual care of patients from their own homes, alerting staff to early signs of deterioration while helping people live independently.

As well as helping British patients feel the benefit of new technology first, by providing regulatory clarity for new AI tools, this approach will attract technology companies to invest in developing and using their latest innovations in the UK, driving forward the government’s plan to build an NHS fit for the future as part of the Plan for Change.

The National Commission on the Regulation of AI in Healthcare is an expert, non-statutory advisory body established by the MHRA to review current regulations and provide recommendations for a new regulatory framework for AI in healthcare.

“I’m honoured to be appointed Chair of the UK National Commission on the Regulation of AI in Healthcare. The safe and effective use of AI in healthcare is one of the defining challenges – and opportunities – of our time. 

“This Commission marks a vital step in ensuring the UK leads the way in responsible innovation, and in accelerating the availability of AI technologies that can support better health for everyone. By bringing together diverse expertise we can build a regulatory framework for AI that is trusted by the public and health professionals, and delivers real benefits for patients.” 

Professor Alastair Denniston, Commission Chair 


The full membership of the Commission is: 

  • Dr Ricardo Baptista Leite, CEO, HealthAI – The Global Agency for Responsible AI in Health 
  • Professor Alastair Denniston, Professor of Regulatory Science and Innovation at the University of Birmingham, Honorary Consultant Ophthalmologist at University Hospitals Birmingham NHS Foundation Trust, and Executive Director of the UK’s Centre of Excellence for Regulatory Science in AI & Digital HealthTech (CERSI-AI) 
  • Professor Henrietta Hughes, Patient Safety Commissioner 
  • Dame Jennifer Dixon, Chief Executive of the Health Foundation 
  • Dr Brian Anderson, CEO of Coalition for Health AI (CHAI) 
  • Richard Stubbs, Chief Executive of Health Innovation Yorkshire & Humber 
  • Professor Neil Lawrence, DeepMind Professor of Machine Learning at the University of Cambridge and Chief Scientist at Trent AI 
  • Professor Cathie Sudlow, Head of School of Population Health Sciences, Director of Usher Institute, University of Edinburgh, Director, UKRI Adolescent Health Study, Director of Generation Scotland 
  • Dr Vish Ratnasuriya MBE, practising GP, Chair of Our Health Partnership, co-founder of Primary Care Accelerator and Hon Assoc Professor University of Birmingham 
  • Dr Gabriella Spinelli, Director of RADIANT-CERSI Centre for Regulatory Science & Innovation in Digital Health & Healthcare AI, Brunel University of London 
    Richard Susskind CBE KC, President of the Society for Computers and Law 
  • Dr Barry Stein, Chief Clinical Innovation Officer, Chief Medical Informatics Officer, Founder of the Center for AI Innovation in Healthcare, Attending Vascular and Interventional Radiologist, Hartford HealthCare

“It is a privilege to contribute with the perspective of HealthAI as a member of the core commission on the regulation of AI in Health. I look forward to working alongside distinguished colleagues from across healthcare and technology sectors.

Together, we will work towards delivering governance and regulatory pathways to accelerate the adoption and scalability of safe and effective AI technologies that can contribute to improving health outcomes across the entirety of the United Kingdom.” 

Ricardo Baptista Leite, CEO, HealthAI

AI has the potential to revolutionise health and social care, but it presents new challenges for regulators. Unlike pills and hardware devices, numerous factors can impact the performance of an AI system over time and across different patient groups. A review of existing frameworks and the creation of new ones are therefore needed to ensure that revolutionary AI technology can be introduced to the NHS rapidly, in a safe, effective, and reliable manner.

Supported by the Health Foundation as a research partner, the Commission will help shape the new rulebook, which is expected to be published next year. This will help enable key commitments in the government’s 10-Year Health Plan for England and Life Sciences Sector Plan to transform the NHS for the benefit of patients, and drive economic growth in the UK’s life sciences sector.

For example, AI is already being used to analyse and interpret acute stroke brain scans to support doctors when diagnosing and making treatment decisions in 100% of stroke units in England. Thanks to the AI Diagnostic Fund, 50% of hospital trusts are now deploying AI to aid in the diagnosis of conditions such as lung cancer. Hospitals using AI-supported diagnostics have seen a 42% reduction in diagnostic errors.

The National Commission’s work will directly support the NHS’s digital transformation, benefiting patients and the UK’s ambition to become a global hub for health tech investment.

Representatives, including those from other regulatory bodies, from across the UK’s healthcare ecosystem and internationally, will have a voice in the AI National Commission, ensuring that advice balances innovation with patient safety.

In June 2025, HealthAI welcomed the United Kingdom as its first member country in its newly created Global Regulatory Network, positioning the MHRA at the forefront of international initiatives to expedite the safe introduction of trusted AI tools into clinical settings.

To view the original UK Government press release, please click HERE.

Cover Image: HealthAI

Previous post
India Joins HealthAI's Global Regulatory Network, Pioneering Safe AI in Health

This feature
is currently locked

close

You need to be logged in

Sign in to continue and unlock this feature.